Atlas Trials

Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation

Clinical trial NCT01938248 · COMPLETED

Trial details

NCT number
NCT01938248
Sponsor
Population Health Research Institute
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Atrial FibrillationStroke
Start date
2015-05-01
Primary completion
2023-10-27
Enrollment
4012

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.